Cleared Traditional

K862325 - THE INJECTOR

K862325 is an FDA 510(k) clearance for THE INJECTOR, manufactured by American Medical Innovations, Inc.. The device is a Class 2 General Hospital device with product code KZH cleared through the Traditional 510(k) pathway after a 253-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1987
Decision
253d
Days
Class 2
Risk

K862325 is an FDA 510(k) clearance for the THE INJECTOR. Classified as Introducer, Syringe Needle (product code KZH), Class II - Special Controls.

Submitted by American Medical Innovations, Inc. (Neosho, US). The FDA issued a Cleared decision on February 27, 1987 after a review of 253 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6920 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K862325

510(k) Number K862325 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 1986
Decision Date February 27, 1987
Days to Decision 253 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 129d · This submission: 253d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KZH Device Classification - Class 2, Special Controls

Product Code KZH Introducer, Syringe Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KZH Introducer, Syringe Needle

All 46
Devices cleared under the same product code (KZH) and FDA review panel - the closest regulatory comparables to K862325.
INSTAJECT II
K883164 · Pavel Jordan & Associates, Inc. · Oct 1988
INJECT-EASE
K872233 · Palco Laboratories, Inc. · Sep 1987
INSTAJECT
K870474 · Pavel Jordan & Associates, Inc. · Mar 1987
DIAMATIC, AUTOMATIC INSULIN INJECTOR
K860284 · Ulster Scientific, Inc. · Apr 1986
MEDI-JECT
K832847 · Jack H. Ritterskamp · Feb 1984
INJECTION AIDE UNIT FOR DIAGETICS
K834440 · Gottinger Co. · Feb 1984